Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Guo

Showing results (441-450 of 2,870) with videos related to

Pageof 287
Sort By:
Zhonghua Nei Ke Za Zhi|March 25, 2021
[Research progress of exosomes in the treatment of doxorubicin-related cardiotoxicity]X X Huang, J F Chi, H Y Guo
American Journal of Surgery|October 28, 2022
The pathogenesis of appendicitis in 2022: More than just a fecalithMichael Y Guo, Amy N Antonsen, Sam M Wiseman
The American Journal of Physiology|October 1, 1998
Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanismsZ He, S Raman, Y Guo, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 1, 1996
Statistical expectation value of the Debye-Waller factor and E(hkl) values for macromolecular crystalsR H Blessing, D Y Guo, D A Langs
Acta Anatomica|December 1, 1998
Adenylyl cyclase type 7 is the predominant isoform in the bovine retinal pigment epitheliumE Beitz, H Völkel, Y Guo, et al.
American Journal of Surgery|August 15, 2024
Role of thymectomy in surgical treatment of renal hyperparathyroidismMichael Y Guo, Michal Pillar, Neraj Manhas, et al.
Functional Neurology|July 1, 1988
Changes of reactions of neurones in dorsal raphe nucleus and locus coeruleus to electroacupuncture by hypothalamic arcuate nucleus stimulationQ H Yin, J R Mao, S Y Guo
Zhonghua Xin Xue Guan Bing Za Zhi|June 15, 2022
[Research progress in the regulation and application prospects of exosomes on atherosclerotic diseases]Y Liu, Z Huang, S Y Guo, et al.
European Review for Medical and Pharmacological Sciences|March 7, 2020
Clinical significance of SLP-2 in epithelial ovarian cancer and its regulatory effect on the Notch signaling pathwayX-Y Guo, H-F Guo, H-M Guo
Die Pharmazie|May 27, 2014
The MEK1/2 inhibitor U0126 reverses imatinib resistance through down-regulating activation of Lyn/ERK signaling pathway in imatinib-resistant K562R leukemia cellsR Shi, J Lin, Y Guo, et al.
Pageof 287

Showing results (441-450 of 2,870) with videos related to

Sort By:
Pageof 287
Zhonghua Nei Ke Za Zhi|March 25, 2021
[Research progress of exosomes in the treatment of doxorubicin-related cardiotoxicity]X X Huang, J F Chi, H Y Guo
American Journal of Surgery|October 28, 2022
The pathogenesis of appendicitis in 2022: More than just a fecalithMichael Y Guo, Amy N Antonsen, Sam M Wiseman
The American Journal of Physiology|October 1, 1998
Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanismsZ He, S Raman, Y Guo, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 1, 1996
Statistical expectation value of the Debye-Waller factor and E(hkl) values for macromolecular crystalsR H Blessing, D Y Guo, D A Langs
Acta Anatomica|December 1, 1998
Adenylyl cyclase type 7 is the predominant isoform in the bovine retinal pigment epitheliumE Beitz, H Völkel, Y Guo, et al.
American Journal of Surgery|August 15, 2024
Role of thymectomy in surgical treatment of renal hyperparathyroidismMichael Y Guo, Michal Pillar, Neraj Manhas, et al.
Functional Neurology|July 1, 1988
Changes of reactions of neurones in dorsal raphe nucleus and locus coeruleus to electroacupuncture by hypothalamic arcuate nucleus stimulationQ H Yin, J R Mao, S Y Guo
Zhonghua Xin Xue Guan Bing Za Zhi|June 15, 2022
[Research progress in the regulation and application prospects of exosomes on atherosclerotic diseases]Y Liu, Z Huang, S Y Guo, et al.
European Review for Medical and Pharmacological Sciences|March 7, 2020
Clinical significance of SLP-2 in epithelial ovarian cancer and its regulatory effect on the Notch signaling pathwayX-Y Guo, H-F Guo, H-M Guo
Die Pharmazie|May 27, 2014
The MEK1/2 inhibitor U0126 reverses imatinib resistance through down-regulating activation of Lyn/ERK signaling pathway in imatinib-resistant K562R leukemia cellsR Shi, J Lin, Y Guo, et al.
Pageof 287